1. Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia

S Rehan Ahmad* , Md Zeyaullah* , Abdullah M. AlShahrani, Mohammad Suhail Khan, Adam Dawria, Ali Mohieldin, Haroon Ali, Abdelrhman AG Altijani, Mohammad Shane Alam, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain, Mohammad Amjad Kamal

Bioimpacts. 2025;15: 30259 | Published on: 2024 Sep 09. doi: 10.34172/bi.30259

PMCID: PMC11954750 PMID: 40161932

Article

PDF

Suppl 1

XML

Cited By:

Original Article

2. A potential mechanism for tau protein modulating in schizophrenia with transcranial direct current stimulation intervention: A randomized controlled trial

Ali Reza Shafiee-Kandjani , Farnaz Chalabianloo* , Sara Farhang , Dariush Shanehbandi , Behzad Shalchi

Bioimpacts. 2025;15: 30274 | Published on: 2024 Jul 22. doi: 10.34172/bi.30274

PMCID: PMC11954739 PMID: 40161936

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons